Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Qlaira versus Microgynon-30 thrombosis risk marker study
NL-OMON21448Recruiting
- Sponsor
- Leiden University Medical Center
- Start
- May 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial in pregnancy comparing Qlaira with Microgynon-30 (2 arms). Primary endpoints: Sex hormone-binding globulin and Activated protein C resistance. Started May 2010; status: recruiting.
02
Drugs
estradiol valerate + dienogestethinylestradiol + levonorgestrel
03
Conditions
pregnancy
Beyond the preview
Go deeper on NL-OMON21448.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON21448.